Regencell Bioscience Holdings L (RGC) Financials

RGC Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 12.6 million 632320
2023-06-30 12.6 million 632320
2023-03-31 12621 632
2022-12-31 15.5 million 873789

RGC Free Cash Flow and Stock based compensation

No data available :(

RGC Net Income

No data available :(

RGC Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.6 million - -
2023-06-30 - - 463669
2023-03-31 11564 - -
2022-12-31 - - -

RGC Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 13.0 million
2023-06-30 13.0 million
2023-03-31 13.0 million
2022-12-31 13.0 million

RGC Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 231455 1041 82
2023-06-30 - - - -
2023-03-31 - 115 1041 82
2022-12-31 - 1.4 million 990 49

RGC Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 769687
2023-06-30 - -
2023-03-31 - -
2022-12-31 - -

RGC

Price: $5.35

52 week price:
3.16
31.30

Payout Ratio Range:
66.57%
255.30%

Earnings Per Share: -0.45 USD

P/E Ratio: -17.78

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 700

Ebitda: 521.8 million

Market Capitalization: 48.3 million

Average Dividend Frequency: 4

Links: